AI-generated summary
The authors studied whether 810 nm pulsed light therapy applied to the scalp of APP/PS1 mice, a model of Alzheimer's disease, affected learning and amyloid-beta burden. They report reduced cortical and hippocampal Aβ42 plaque burden and an exploratory association with reversal-learning performance. As an animal study with exploratory analyses, the findings are preliminary and do not establish a treatment effect in people.
- Who or what was studied
- APP/PS1 mice (an Alzheimer's disease mouse model)
- Wavelengths
- 810 nm
- Limits stated in the abstract
- Findings come from an animal study, with exploratory correlation analyses and a histological subset that is not described as a full cohort.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 13.5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Dementia, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.